Quarterly report pursuant to Section 13 or 15(d)

Sponsored Research and Clinical Trial Agreements (Tables)

v3.20.2
Sponsored Research and Clinical Trial Agreements (Tables)
6 Months Ended
Jun. 30, 2020
Mustang [Member]  
Schedule of research and development for sponsored research and clinical trial agreements

For the three and six months ended June 30, 2020 and 2019, Mustang recorded the following expense in research and development for sponsored research and clinical trial agreements:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended June 30, 

​

For the Six Months Ended June 30, 

($ in thousands)

    

2020

    

2019

    

2020

    

2019

COH CAR T

​

$

—

​

$

500

​

$

500

​

$

1,000

COH – CD123 (MB-102)

​

 

65

​

 

456

​

 

296

​

 

759

COH - IL13Rα2 (MB-101)

​

 

234

​

 

225

​

 

326

​

 

567

COH – Manufacturing

​

 

—

​

 

115

​

 

—

​

 

229

COH - CS1 (MB-104)

​

​

770

​

​

—

​

​

770

​

​

—

Beth Israel Deaconess Medical Center - CRISPR

​

​

—

​

​

—

​

​

—

​

​

69

St. Jude – XSCID (MB-107)

​

​

1,558

​

​

—

​

​

1,558

​

​

—

Fred Hutch - CD20 (MB-106)

​

​

189

​

​

374

​

​

716

​

​

641

Total

​

$

2,816

​

$

1,670

​

$

4,166

​

$

3,265